Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 90501-90550 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05229874
Effect of CNSI vs. ICG in Lymph Node Tracing During Gastrectomy
PHASE2Active, not recruiting
96 participants
Started: Jan 20, 2022 · Completed: Jan 20, 2025
1 condition1 sponsor1 location
NCT05132686
The Healthy Diet and Lifestyle Study II
NARecruiting
260 participants
Started: Jan 20, 2022 · Completed: Sep 30, 2026
1 condition4 sponsors1 location
NCT04141514
Effects of Short-term Therapeutic Fasting on Nausea and Vomiting Due to Chemotherapy
NARecruiting
30 participants
Started: Jan 20, 2022 · Completed: Jun 19, 2025
2 conditions1 sponsor1 location
NCT05229835
Effect of Time-restricted Eating and Endurance Training on Markers of the Health of Women and Men
NAActive, not recruiting
300 participants
Started: Jan 20, 2022 · Completed: Dec 31, 2027
5 conditions1 sponsor1 location
NCT05011188
FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer
PHASE1/PHASE2Active, not recruiting
44 participants
Started: Jan 19, 2022 · Completed: Jul 31, 2027
2 conditions3 sponsors1 location
NCT05308862
PROSENIOR. Prevention of Pressure Ulcers, Malnutrition, Poor Oral Health and Falls Among Older Persons Receiving Municipal Health Care and Are Registered in the Quality Registry Senior Alert
NARecruiting
330 participants
Started: Jan 19, 2022 · Completed: Dec 31, 2025
4 conditions2 sponsors1 location
NCT05046444
Solving Riddles Through Sequencing
N/ARecruiting
100 participants
Started: Jan 19, 2022 · Completed: Oct 1, 2026
6 conditions2 sponsors1 location
NCT05308459
Data Health VET - Data-driven Health Promotion at Vocational Education and Training Schools
NAActive, not recruiting
1,370 participants
Started: Jan 19, 2022 · Completed: Jun 30, 2025
6 conditions3 sponsors2 locations
NCT06833450
Reliability of IUS in Crohn's Disease
NARecruiting
30 participants
Started: Jan 19, 2022 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT05224986
Lifestyle Patterns and Glycemic Control
NARecruiting
34 participants
Started: Jan 19, 2022 · Completed: Jun 1, 2026
1 condition3 sponsors1 location
NCT05150197
Virtual Reality Visual Field Testing as an Alternative in Childhood Eye Disease
NARecruiting
1,000 participants
Started: Jan 19, 2022 · Completed: Feb 1, 2026
1 condition1 sponsor1 location
NCT05267912
Prospective Multicenter Study Evaluating Feasibility and Efficacy of Tumor Organoid-based Precision Medicine in Patients With Advanced Refractory Cancers
NAActive, not recruiting
61 participants
Started: Jan 19, 2022 · Completed: Jan 18, 2028
1 condition1 sponsor1 location
NCT04482244
RCT of CBD for Anxiety in Advanced Breast Cancer
PHASE2Active, not recruiting
60 participants
Started: Jan 19, 2022 · Completed: Dec 1, 2026
3 conditions2 sponsors1 location
NCT04189133
Rec-LH PD and Safety Profile in Hypogonadotropic Hypogonadism Men
PHASE2Recruiting
32 participants
Started: Jan 19, 2022 · Completed: Jan 18, 2026
1 condition1 sponsor5 locations
NCT04967170
A Study to Evaluate Platelet Rich Plasma to Treat Vulvar Lichen Sclerosus
PHASE1/PHASE2Active, not recruiting
30 participants
Started: Jan 19, 2022 · Completed: Feb 2, 2026
1 condition1 sponsor1 location
NCT04926792
Taiwan Registry for Leadless Pacemaker
N/AEnrolling by invitation
300 participants
Started: Jan 19, 2022 · Completed: Dec 31, 2028
2 conditions3 sponsors1 location
NCT06036719
Interstitial Lung Disease: A Study From Infancy to Elderly Including Relatives
N/ARecruiting
3,000 participants
Started: Jan 19, 2022 · Completed: Mar 19, 2031
1 condition1 sponsor1 location
NCT04884542
Multigen Plus H Study and AMF TT Cones
N/ARecruiting
43 participants
Started: Jan 19, 2022 · Completed: Jun 30, 2027
1 condition2 sponsors2 locations
NCT05443711
Sarcopenic Obesity as a Risk of Premature Aging
N/AActive, not recruiting
75 participants
Started: Jan 19, 2022 · Completed: Dec 31, 2024
3 conditions2 sponsors1 location
NCT05219695
Medical Imaging and Thermal Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI)
NARecruiting
36 participants
Started: Jan 19, 2022 · Completed: May 31, 2026
2 conditions1 sponsor1 location
NCT05069051
Belimumab in Patients with Chronic Lymphocytic Leukemia
PHASE2Active, not recruiting
120 participants
Started: Jan 19, 2022 · Completed: Jul 14, 2027
1 condition2 sponsors1 location
NCT05262140
In Vivo Quantification of Cervical Collar Efficacy
N/ARecruiting
60 participants
Started: Jan 19, 2022 · Completed: Jan 19, 2025
1 condition1 sponsor1 location
NCT05272709
TT-702 in Patients With Advanced Solid Tumours.
PHASE1/PHASE2Recruiting
188 participants
Started: Jan 19, 2022 · Completed: Jun 30, 2027
1 condition2 sponsors3 locations
NCT05084053
A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN)
PHASE3Active, not recruiting
26 participants
Started: Jan 19, 2022 · Completed: Oct 31, 2025
2 conditions1 sponsor23 locations
NCT05051254
Respiratory Muscles and Work of Breathing in Children
NARecruiting
550 participants
Started: Jan 19, 2022 · Completed: Jan 31, 2028
7 conditions2 sponsors1 location
NCT05145296
The Safety/Efficacy Of Daratumumab With Belatacept In Highly HLA-Sensitized Patients Awaiting Kidney Transplantation
NARecruiting
12 participants
Started: Jan 19, 2022 · Completed: Nov 2, 2025
2 conditions2 sponsors1 location
NCT05219045
Ohio RETAIN Impact Evaluation
NARecruiting
3,200 participants
Started: Jan 19, 2022 · Completed: Feb 29, 2028
1 condition2 sponsors1 location
NCT05344599
Evaluating the Prevalence of Acute Hepatic Porphyria in Postural Tachycardia Syndrome
N/AActive, not recruiting
70 participants
Started: Jan 19, 2022 · Completed: Dec 30, 2025
2 conditions1 sponsor1 location
NCT05166265
Clinical Investigation Study of Safety and Performance of the Sentio System.
NAActive, not recruiting
51 participants
Started: Jan 19, 2022 · Completed: Nov 30, 2025
3 conditions1 sponsor6 locations
NCT05214742
Developing Derived Induced Pluripotent Stem Cells as a Model to Understand Imprinted Disorders
N/AEnrolling by invitation
20 participants
Started: Jan 19, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05197049
A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease
PHASE3Active, not recruiting
350 participants
Started: Jan 19, 2022 · Completed: Oct 30, 2028
1 condition1 sponsor344 locations
NCT05107310
The Spinal Navigation Trial - Surgical Navigation or Free Hand Technique in Spine Surgery
NAActive, not recruiting
62 participants
Started: Jan 18, 2022 · Completed: Jun 30, 2029
2 conditions3 sponsors1 location
NCT06367101
AR Stimulation Effects on Gait, Anxiety, and Brain Connectivity in Parkinson's Disease
NARecruiting
90 participants
Started: Jan 18, 2022 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT04965077
Treatment of Advanced and Metastatic Solid Tumors With MIL97
PHASE1Recruiting
62 participants
Started: Jan 18, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04861064
Weekly Sirolimus Therapy
PHASE2Recruiting
24 participants
Started: Jan 18, 2022 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT06081478
CD19/CD22 Bispecific CAR-T Cell Therapy for Relapsed/Refractory B-cell Lymphoma or Acute Lymphoblastic Leukemia
PHASE2Recruiting
100 participants
Started: Jan 18, 2022 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT05215470
CLARA: Somatic and Germline Mechanisms That Impact Renal Cancer Immunotherapy
PHASE2Active, not recruiting
100 participants
Started: Jan 18, 2022 · Completed: Nov 30, 2026
1 condition3 sponsors1 location
NCT06141109
Treatment of MB07133 Plus Sintilimab in Patients With Hepatocellular Carcinoma
PHASE1/PHASE2Recruiting
39 participants
Started: Jan 18, 2022 · Completed: Dec 31, 2025
3 conditions2 sponsors1 location
NCT06080607
PRO Survivorship Concerns ITA
N/ARecruiting
280 participants
Started: Jan 18, 2022 · Completed: Jun 18, 2024
3 conditions5 sponsors2 locations
NCT05180981
Imaging Brain Fluids During Breathing
NARecruiting
80 participants
Started: Jan 18, 2022 · Completed: May 1, 2026
1 condition2 sponsors2 locations
NCT05200923
Pelvic Health Electrically Evoked Recording (PEER) 2 Study
NAActive, not recruiting
300 participants
Started: Jan 18, 2022 · Completed: Dec 18, 2026
3 conditions1 sponsor6 locations
NCT04743505
Safety and Efficacy of Combining APL-101 With Frontline Osimertinib in Patients With EGFR-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)
PHASE1/PHASE2Recruiting
27 participants
Started: Jan 18, 2022 · Completed: May 31, 2030
1 condition2 sponsors1 location
NCT05031507
Study of Skeletal Disorders
N/ARecruiting
100 participants
Started: Jan 18, 2022 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT05223413
REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs
NARecruiting
608 participants
Started: Jan 18, 2022 · Completed: Dec 31, 2026
2 conditions2 sponsors24 locations
NCT05044845
Needs Assessment of Knowledge, Beliefs, and Attitudes of Patients With Hemophilia B About Gene Therapy
N/ARecruiting
150 participants
Started: Jan 18, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor6 locations
NCT04706715
LAG3 PET Imaging in Advanced Solid Tumors
PHASE1/PHASE2Active, not recruiting
41 participants
Started: Jan 18, 2022 · Completed: Nov 30, 2025
1 condition2 sponsors1 location
NCT05654077
EBV CAR-T Cells for Nasopharyngeal Carcinoma
EARLY_PHASE1Recruiting
24 participants
Started: Jan 18, 2022 · Completed: Dec 30, 2025
1 condition2 sponsors1 location
NCT05472168
Impact of Olfactory Odour StimulatioN on Energy EXpenditure
NARecruiting
58 participants
Started: Jan 18, 2022 · Completed: Oct 30, 2024
1 condition1 sponsor1 location
NCT04837352
Therapeutic Adherence of Multiple Sclerosis Patients
N/ARecruiting
153 participants
Started: Jan 18, 2022 · Completed: Oct 18, 2025
1 condition1 sponsor4 locations
NCT04924712
INS, B Cells and Microbiota
N/ARecruiting
30 participants
Started: Jan 18, 2022 · Completed: Jan 18, 2026
4 conditions1 sponsor2 locations